Navigation Links
Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy

ur technology to prove safe or effective; our inability to obtain regulatory approval for our technology, which is only in the clinical development stage; delay or failure to complete clinical studies; our dependence on our license agreement with Aruba International B.V.; our reliance on collaborations with strategic partners and consultants; competition in our industry, including the development of new products by others that may provide alternative or better therapies; failure to secure and enforce our intellectual property rights; risks associated with use of biological and hazardous materials; acceptance of our potential products by healthcare providers and patients; our exposure to product liability claims; and our dependence on key personnel.

This release should be read in conjunction with the consolidated financial statements and notes thereto included in our most recent reports on Form 10-K and Form 10-Q. Copies are available through the SEC's Electronic Data Gathering Analysis and Retrieval system (EDGAR) at www.sec.gov. Lipid Sciences assumes no obligation to update the forward-looking statements included in this document.

Press releases for Lipid Sciences, Inc. are available on our website: www.lipidsciences.com. If you would like to receive our press releases via email, please contact: info@lipidsciences.com.

FOR FURTHER INFORMATION CONTACT:
Deborah S. Lorenz
Vice President, Investor Relations and
Corporate Communications
Lipid Sciences, Inc.
925-249-4031
Contact via http://www.marketwire.com/mw/emailprcntct?id=4D79E4FEB6C8C350

SOURCE: Lipid Sciences, Inc.


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Inspire Announces Presentations at Two European Scientific Conferences
6. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
7. IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
8. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
9. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
10. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
11. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
Post Your Comments:
(Date:7/23/2014)... YORK , July 23, 2014  When it comes ... Wagner is ready to roll out the red carpet. ... welcome an influx of HAL 9000-like robots into our human ... right now, there,s a pressing need to apply new technologies ... The worldwide market for medical robotics is expected to increase ...
(Date:7/23/2014)... July 23, 2014 Research and Markets ... Medical Gloves (Exam and Surgical) Markets Worldwide 2014" ... http://photos.prnewswire.com/prnh/20130307/600769 The purpose of this report ... Disposable Medical (Exam and Surgical) Gloves. The report discusses ... these products. Topics covered include product definitions, ...
(Date:7/23/2014)... July 23, 2014  Lightlake Therapeutics Inc. ("Lightlake") ... based on its expertise in opioid antagonists, announced ... drug application ("IND") with respect to its naloxone-based ... today that it has received an additional commitment ... part of the National Institutes of Health ("NIH"), ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3
... Pharmaceuticals, Inc. (NASDAQ: IDIX ), a biopharmaceutical company ... treatment of human viral diseases, today announced that it has ... common stock. All of these shares are being sold by ... sole book-running manager and underwriter for the offering.  Idenix intends ...
... RSB Spine, LLC, today announced allowance of ... its line of InterPlate® cervical and lumbar intervertebral ... of the most common spinal procedures performed by ... numerous disc replacement implants," commented James M. Moran, ...
Cached Medicine Technology:Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock 2
(Date:7/23/2014)... Karen Pallarito HealthDay Reporter ... wild day for Obamacare, two federal appeals courts arrived at ... provided to millions of Americans who bought health insurance through ... the matter is headed for a showdown before the U.S. ... U.S. Appeals Court for the District of Columbia Circuit said ...
(Date:7/23/2014)... The European Vitamins Market report explains ... and projection of revenue. The market in Europe is ... to $1,202.08 million by 2018, at a CAGR of ... TOC of the European Vitamins Market report, to get ... provides a glimpse of the segmentation in the European ...
(Date:7/23/2014)... The European Bio fertilizers Market Report defines ... analysis and forecast of revenue. The bio fertilizers market ... 2,566.4 million in 2012 to $4,582.2 million by 2017, ... , Browse through the TOC of the European Bio ... in-depth analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , ...
(Date:7/23/2014)... Bethesda, MD (July 23, 2014) Statins, a class ... reduce a patient,s risk of developing Barrett,s esophagus, according ... , the official journal of the American ... risk reduction with statin use. , "Patients who received ... of having Barrett,s esophagus compared to non-users," said study ...
(Date:7/23/2014)... July 23, 2014 According to a ... by Form Factor (Integrated Circuit IP, SOC IP), Design ... Application, Geography and Verification IP - Forecast & Analysis ... is expected to grow at a CAGR of 12.6% ... 2020. , Browse more than 76 market data tables ...
Breaking Medicine News(10 mins):Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6
... a leading provider of laser vision correction services under ... center in Des,Moines, Iowa. This marks the 74th LasikPlus ... vision center in the state of Iowa.,LasikPlus vision centers ... Similar to other LasikPlus vision centers throughout the ...
... Highlights Myriad Opportunities for Using Wireless ... Efficiency and Accuracy of Patient Care, WALTHAM, Mass., ... intelligent wireless LANs (WLANs) for enterprises and,service providers, will ... Exhibition, taking place February 24-28 in Orlando, FL, to,showcase ...
... ECG Devices Help Healthcare Organizations Deliver Clinical ... Data Faster and ... Networks, the leading,global provider of intelligent wireless LANs (WLANs) ... Corporation,(Nasdaq: CSCX ) ( http://www.cardiacscience.com ), the leading ...
... of, CellCept Will Provide Effective Treatment Options, According ... ... Feb. 25 Decision Resources, one of the,world,s leading research ... entry and uptake of high-priced branded,agents will drive the systemic ...
... HealthVault Empowers Patients to Orchestrate Health ... ... the leading provider,of next generation healthcare connectivity solutions, today announced ... using Microsoft(R) HealthVault(TM), at the 2008 HIMSS,(Healthcare Information and Management ...
... Hyperion,Therapeutics, Inc. today announced that the first ... trial of AMMONUL(R) (sodium phenylacetate and sodium,benzoate) Injection ... hepatic,encephalopathy (HE). The randomized, double-blind study is designed ... standard of care in,hospitalized adults. The FDA has ...
Cached Medicine News:Health News:LCA-Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines, Iowa 2Health News:Colubris Demonstrates Wide-Ranging Mobility Solutions for Healthcare 2Health News:Cardiac Science Corporation Selects Colubris Networks' Wireless Solution for its Portable Electrocardiograph 2Health News:Cardiac Science Corporation Selects Colubris Networks' Wireless Solution for its Portable Electrocardiograph 3Health News:Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016 2Health News:Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08 2Health News:Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08 3Health News:Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy 2Health News:Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy 3
Scorpio CR Knee is designed to address normal knee kinematics, range of motion (ROM) and polyethylene wear....
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
... Knee System has been ... refined with the aid ... and manufacturing technology. Its ... stability, function, performance and ...
... image guided surgery system offers full-featured ... design and use. It provides unparalleled ... localize critical anatomy and plan optimal ... surgeons an easy-to-use, technologically advanced approach ...
Medicine Products: